Back
Protagonist Therapeutics Stock Price Chart
Sell
47
PTGX
Protagonist Therapeutics
Last Price:
28.16
Seasonality Move:
26.95%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.76 | Sell |
| 20-day SMA: | 29.2 | Sell |
| 50-day SMA: | 27.87 | Buy |
| 200-day SMA: | 22.91 | Buy |
| 8-day EMA: | 29.13 | Sell |
| 20-day EMA: | 29.02 | Sell |
| 50-day EMA: | 28.22 | Sell |
| 200-day EMA: | 24.61 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 46.22 | Sell |
| Chaikin Money Flow: | -24408 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.1 - 30.78) | Sell |
| Bollinger Bands (100): | (25.58 - 29.82) | Buy |
Protagonist Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 28.15 while PTGX 8-day simple moving average is 29.76, which is a Sell signal.
- The stock price of PTGX is 28.15 while Protagonist Therapeutics 20-day SMA is 29.20, which makes it a Sell.
- Protagonist Therapeutics 50-day simple moving average is 27.87 while PTGX share price is 28.15, making it a Buy technically.
- PTGX stock price is 28.15 and Protagonist Therapeutics 200-day simple moving average is 22.91, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
47
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $28.15. The Score for PTGX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
1.65B
Price in USD:
28.15
Share Volume:
437.47K
Protagonist Therapeutics 52-Week Range
52-Week High:
33.34
52-Week Low:
13.72
Sell
47
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 28.15 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 28.15 while PTGX 8-day exponential moving average is 29.13, which is a Sell signal.
- The stock price of PTGX is 28.15 while Protagonist Therapeutics 20-day EMA is 29.02, which makes it a Sell.
- Protagonist Therapeutics 50-day exponential moving average is 28.22 while PTGX share price is 28.15, making it a Sell technically.
- PTGX stock price is 28.15 and Protagonist Therapeutics 200-day simple moving average is 24.61, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is 0.44, suggesting Protagonist Therapeutics is a Buy
- Protagonist Therapeutics Relative Strength Index (RSI) is 46.22, which suggest Protagonist Therapeutics is oversold
- The Bollinger Bands (25) for Protagonist Therapeutics is (26.1 - 30.78), which suggest Protagonist Therapeutics is a Buy
- The Bollinger Bands (100) for Protagonist Therapeutics is (25.58 - 29.82), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.